Amarin (AMRN) Beats on EPS, Misses Revenue

Amarin Corporation plc (AMRN) shares are up $0.07, or 4.55%, to $1.61 in after-hours trading Tuesday after the company reported its fourth quarter earnings results. The biopharmaceutical firm reported non-GAAP earnings of ($0.11) per share on revenues of $16.48 million, up 63.1% from a year ago. Analysts were expecting EPS of ($0.13) on revenues of […] View the full post at: Amarin (AMRN) Beats on EPS, Misses Revenue Related posts: Rethinking California’s Revenue Structure Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock